<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000405813"><TermName>SGN-40</TermName><TermDefinition><DefinitionText>A monoclonal antibody that binds to cells that have the CD40 antigen on their surface, including cells from multiple myeloma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. SGN-40 is being studied in the treatment of cancer. It is a type of monoclonal antibody.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>SGN-40</SpanishTermName><SpanishTermDefinition><DefinitionText>Anticuerpo monoclonal que se une a las células que tienen el antígeno CD40 sobre sus superficies, como las células del mieloma múltiple, del linfoma no Hodgkin y de la leucemia linfocítica crónica. El SGN-40 está en estudio para el tratamiento de cáncer. Es un tipo de anticuerpo monoclonal.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-11-05</DateFirstPublished><DateLastModified>2007-09-21</DateLastModified></GlossaryTerm>
